Literature DB >> 10495582

Potential cost savings in residential care for Alzheimer's disease patients.

J Leon1, D Moyer.   

Abstract

Data from a 1996 cross-sectional study examining the costs of care for Alzheimer's Disease patients are used to estimate the potential cost savings that could result by substituting assisted living for nursing home care for AD residents with health profiles that appear to be manageable within assisted living facilities that specialize in dementia care. Results indicate that up to 13.9% of nursing home costs could be saved, making such a service substitution an attractive alternative in the provision of residential care for certain categories of AD patients.

Entities:  

Mesh:

Year:  1999        PMID: 10495582     DOI: 10.1093/geront/39.4.440

Source DB:  PubMed          Journal:  Gerontologist        ISSN: 0016-9013


  3 in total

1.  Resource utilisation and cost analysis of memantine in patients with moderate to severe Alzheimer's disease.

Authors:  Anders Wimo; Bengt Winblad; Albrecht Stöffler; Yvonne Wirth; Hans-Jörg Möbius
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  Galantamine: a pharmacoeconomic review of its use in Alzheimer's disease.

Authors:  Katherine A Lyseng-Williamson; Greg L Plosker
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

3.  Trends in mental health admissions to nursing homes, 1999-2005.

Authors:  Catherine Anne Fullerton; Thomas G McGuire; Zhanlian Feng; Vincent Mor; David C Grabowski
Journal:  Psychiatr Serv       Date:  2009-07       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.